Indraprastha Medical Corporation Limited stock analysis
Want to see IN:INDRAMEDCO full AI Analyst Report?
Indraprastha Medical Corporation Limited (INDRAMEDCO) Stock Price & Analysis
INDRAMEDCO Stock Chart & Stats
- Day’s Range
- INR 332.00 - INR 339.35
- 52-Week Range
- INR 293.50 - INR 555.75
- Previous Close
- INR 331.60
- Volume
- 350.29K
- Average Volume (3M)
- 9,281
- Market Cap
- INR 30.40B
- Enterprise Value
- INR 28.89B
- Total Cash (Recent Filing)
- INR 2.63B
- Total Debt (Recent Filing)
- INR 0
- Price to Earnings (P/E)
- 16.2
- Beta
- 1.56
- Next Earnings
- Feb 09, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 18, 2026
- Dividend Yield
- 1.21%
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue Growth
Revenue increased from 6.13B in 2021 to 14.83B in 2026, with positive growth in each of the last five years. This sustained expansion indicates broader hospital activity and supports a larger operating base, even as the latest growth rate moderated.
Profitability Recovery
The substantial improvement in net and EBIT margins shows that the company has converted revenue growth into materially stronger operating economics. A healthier margin structure can support reinvestment, resilience, and more dependable earnings generation over the next several quarters.
Low Financial Leverage
Very low leverage and a much larger equity base provide financial flexibility as the business scales. Limited reliance on debt reduces balance-sheet strain and leaves greater capacity to absorb operating variability or fund future needs without excessive financing pressure.
Bears Say
Slowing Latest Growth
Although the long-term growth record remains positive, the slowdown to roughly 5.5% in 2026 indicates that recent expansion has lost momentum. If this moderation persists, it could limit operating leverage and make future profit growth more dependent on margin improvement.
Gross Margin Volatility
The pronounced variation in gross margin suggests that service mix or cost economics have not been consistently stable. Even with stronger EBIT margins, recurring gross-margin swings can make profitability less predictable and complicate long-term planning and reinvestment decisions.
Uneven Cash-flow Pattern
Cash generation is strong overall, but the year-to-year pattern has been uneven, with a 2025 setback before the 2026 rebound. Such volatility may reflect working-capital or spending timing effects and can reduce confidence in the consistency of near-term internally generated funding.
Indraprastha Medical Corporation Limited News
INDRAMEDCO FAQ
What was Indraprastha Medical Corporation Limited’s price range in the past 12 months?
What is Indraprastha Medical Corporation Limited’s market cap?
When is Indraprastha Medical Corporation Limited’s upcoming earnings report date?
How were Indraprastha Medical Corporation Limited’s earnings last quarter?
Is Indraprastha Medical Corporation Limited overvalued?
Does Indraprastha Medical Corporation Limited pay dividends?
What is Indraprastha Medical Corporation Limited’s EPS estimate?
How many shares outstanding does Indraprastha Medical Corporation Limited have?
What happened to Indraprastha Medical Corporation Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Indraprastha Medical Corporation Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Indraprastha Medical Corporation Limited
Indraprastha Medical Corporation Limited (IMCL) is a prominent Indian healthcare provider, delivering a broad spectrum of hospital services across the nation. The company offers comprehensive medical and surgical solutions across an extensive range of specialties. Its offerings encompass areas like anesthesiology, pediatrics, elder care, genomic medicine, preventative health checks, and a variety of complex surgical interventions, including bariatric, metabolic, bone marrow, cardiac, endovascular, laparoscopic, robotic, spine, pediatric urology, pediatric surgery, transplant, and urology and andrology. Furthermore, IMCL provides specialized medical departments for cancer, cardiology, dermatology, dietetics and clinical nutrition, emergency care, endocrinology/diabetes, ENT, fetal medicine, gastroenterology and hepatology, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedics, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, and transfusion medicine. In addition to its core hospital services, IMCL also operates dedicated cosmetic and dental clinics. Established in 1988, the corporation is headquartered in New Delhi, India.
- Sector
- General
- Industry
- Medical - Care Facilities
- CEO
- Shivakumar Pattabhiraman
- Employees
- 3,000
- Website
- www.delhi.apollohospitals.com
- Address
- Sarita Vihar, New Delhi, DE, 110076, IN
Indraprastha Medical Corporation Limited (INDRAMEDCO) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 6 | 0 | 6 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:APOLLOHOSPApollo Hospitals Enterprise Limited | ||
| IN:ARTEMISMEDArtemis Medicare Services Ltd. | ||
| IN:FORTISFortis Healthcare Ltd. | ||
| IN:MAXHEALTHMax Healthcare Institute Ltd | ||
| IN:MEDANTAGlobal Health Limited |



